InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Gray Susannah, 董事. Insider active across 2 companies, notably Maravai Lifesciences Holdings, INC.. Aggregated, 9 disclosures have been logged. History available since 19 November 2021. The latest transaction was filed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gray Susannah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
6,009 股Ordinary SharesSEC:0001833453-26-000006:0
46,293 股0Class A Common StockSEC:0001833453-26-000004:0
89,139 股@ US$2.1644.7% 占其流量Class A Common StockSEC:0001823239-25-000088:0
10,649 股0Ordinary SharesSEC:0001415889-25-014009:0
20,645 股@ US$10.78100.0% 占其流量Class A Common StockSEC:0001823239-24-000072:0
10,537 股0Ordinary SharesSEC:0001415889-24-012913:0
24,000 股0Class A Common StockSEC:0001823239-23-000059:0
9,132 股0Ordinary SharesSEC:0001415889-23-007376:0
4,271 股0Class A Common StockSEC:0000899243-21-045773:0
9 条申报中的 9 条
About Gray Susannah
Susannah Gray is a Director and declarant for Maravai Lifesciences Holdings, INC. and Theravance Biopharma, Inc. The record shows 9 filings in total, with recent sampled filings dated from 2021-11-23 to 2026-06-16, a modal transaction nature of Attribution, and top_filings amounts ranging from EUR 205825.9937570995 on 2024-05-24 at Maravai Lifesciences Holdings, INC. to EUR 166682.0878603167 on 2025-06-18 at Maravai Lifesciences Holdings, INC., with an additional 2026-06-16 filing at Theravance Biopharma, Inc. with no amount stated.
